Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2003 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Surplus protein myopathies.
Goebel HH, Warlo IA. Goebel HH, et al. Neuromuscul Disord. 2001 Jan;11(1):3-6. doi: 10.1016/s0960-8966(00)00165-6. Neuromuscul Disord. 2001. PMID: 11166159 Review.
This emerging group of congenital myopathies is clinically, immunohistochemically, and genetically diverse. Clinically, early- and late-onset diseases with variable courses are described. Immunohistochemically, mutant gene-related and other proteins have been identified by …
This emerging group of congenital myopathies is clinically, immunohistochemically, and genetically diverse. Clinically, early- and late-onse …
Hyaline body myopathy.
Barohn RJ, Brumback RA, Mendell JR. Barohn RJ, et al. Neuromuscul Disord. 1994 May;4(3):257-62. doi: 10.1016/0960-8966(94)90027-2. Neuromuscul Disord. 1994. PMID: 7522681
Hyaline body myopathy most likely represents a distinct congenital myopathy because of its childhoot-onset, non-progressive course, and distinct morphological features....
Hyaline body myopathy most likely represents a distinct congenital myopathy because of its childhoot-onset, non-progressive course, a …
Autosomal dominant hyaline body myopathy: clinical variability and pathologic findings.
Bohlega S, Lach B, Meyer BF, Al Said Y, Kambouris M, Al Homsi M, Cupler EJ. Bohlega S, et al. Neurology. 2003 Dec 9;61(11):1519-23. doi: 10.1212/01.wnl.0000096022.09887.9d. Neurology. 2003. PMID: 14663035
All biopsies showed "myopathic" changes, angulated neurogenic fibers, and fiber type grouping. There was no correlation between HB and course of disease; the progressive cases displayed more severe myopathic features. ...
All biopsies showed "myopathic" changes, angulated neurogenic fibers, and fiber type grouping. There was no correlation between HB and co